ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Walter J Scott
Jane L Schwabe
Jeffrey T Sugimoto
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scott, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scott, W. J.

Ann Thorac Surg 1994;58:698-703
© 1994 The Society of Thoracic Surgeons

Articles

Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose

Walter J Scott, MD*, Jane L Schwabe, MD, Naresh C Gupta, MD, Naresh A Dewan, MBBS, Steve D Reeb, MD, Jeffrey T Sugimoto, MD The Members of The PET-Lung Tumor study Group*

Departments of Surgery, Pulmonary Medicine, and Radiology, Creighton University Medical Center and Omaha Veterans Affairs Medical Center, Omaha, Nebraska USA

* Address reprint requests to Dr Scott, Department of Surgery, Creighton University Medical Center, 601 N 30th St, Omaha, NE 68131.

Positron emission tomography detects increased glucose uptake in malignant tissue using the glucose analogue [2-18F]fluoro-2-deoxy-D-glucose. We reviewed the scans obtained in 62 patients with lung tumors. All had undergone computed tomography and had tissue-based diagnoses: 22 had adenocarcinomas, 12 had squamous cell carcinomas, 13 had other malignancies, 1 had organizing pneumonia, 1 had a hamartoma, and 13 had granulomas. Positron emission tomography with [2-18F]fluoro-2-deoxy-D-glucose identified 44 of 47 malignancies. Two of three false-negative findings were tumors that were 1 cm2 or less and the other was a bronchioloalveolar carcinoma. All three false-positive findings were granulomas. The sensitivity and specificity of the technique were 93.6% and 80%, respectively, and the positive and negative predictive values were 93.6% and 80%, respectively. The differential uptake ratio was determined in all 62 patients. The mean differential uptake ratio (± the standard error of the mean) for malignant tumors was 6.4 ± 0.56 and that for benign tumors was 1.14 ± 0.26 (p < 0.0001, t test). Twenty-five of the patients had N2 lymph nodes evaluated pathologically. Positron emission tomography with [2-18F]fluoro-2-deoxy-D-glucose identified negative N2 nodes in 19 of 22 patients (86%) with negative nodes and positive N2 nodes in 2 of 3 patients (66%) with positive nodes, including one instance missed by computed tomography. Positron emission tomography with [2-18F]fluoro-2-deoxy-D-glucose is a highly accurate and noninvasive method for identifying malignant lung tumors. The clinical application of this imaging technique in the evaluation of N2 lymph nodes awaits the results of ongoing prospective studies.




This article has been cited by other articles:


Home page
 J. Thorac. Cardiovasc. Surg.Home page
M. Sanli, A. F. Isik, S. Zincirkeser, O. Elbek, A. Mete, B. Tuncozgur, and L. Elbeyli
Reliability of positron emission tomography-computed tomography in identification of mediastinal lymph node status in patients with non-small cell lung cancer
J. Thorac. Cardiovasc. Surg., November 1, 2009; 138(5): 1200 - 1205.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
Y. Ohba, H. Nomori, H. Shibata, H. Kobayashi, T. Mori, S. Shiraishi, and R. Nakashima
Evaluation of Semiquantitative Assessments of Fluorodeoxyglucose Uptake on Positron Emission Tomography Scans for the Diagnosis of Pulmonary Malignancies 1 to 3 cm in Size
Ann. Thorac. Surg., March 1, 2009; 87(3): 886 - 891.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
B. Goudarzi, H. A. Jacene, and R. L. Wahl
Diagnosis and Differentiation of Bronchioloalveolar Carcinoma from Adenocarcinoma with Bronchioloalveolar Components with Metabolic and Anatomic Characteristics Using PET/CT
J. Nucl. Med., October 1, 2008; 49(10): 1585 - 1592.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
Y. C. Ung, D. E. Maziak, J. A. Vanderveen, C. A. Smith, K. Gulenchyn, C. Lacchetti, W. K. Evans, and Lung Cancer Disease Site Group of Cancer Care Onta
18Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis and Staging of Lung Cancer: A Systematic Review
J Natl Cancer Inst, December 5, 2007; 99(23): 1753 - 1767.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
D. L. Chen and F. Dehdashti
Advances in Positron Emission Tomographic Imaging of Lung Cancer
Proceedings of the ATS, December 1, 2005; 2(6): 541 - 544.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
H. Nomori, K. Watanabe, T. Ohtsuka, T. Naruke, K. Suemasu, and K. Uno
Visual and Semiquantitative Analyses for F-18 Fluorodeoxyglucose PET Scanning in Pulmonary Nodules 1 cm to 3 cm in Size
Ann. Thorac. Surg., March 1, 2005; 79(3): 984 - 988.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
O. Birim, A. P. Kappetein, T. Stijnen, and A. J.J.C. Bogers
Meta-Analysis of Positron Emission Tomographic and Computed Tomographic Imaging in Detecting Mediastinal Lymph Node Metastases in Nonsmall Cell Lung Cancer
Ann. Thorac. Surg., January 1, 2005; 79(1): 375 - 382.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
J.-H. Chung, K.-J. Cho, S.-S. Lee, H. J. Baek, J.-H. Park, G. J. Cheon, C.-W. Choi, and S. M. Lim
Overexpression of Glut1 in Lymphoid Follicles Correlates with False-Positive 18F-FDG PET Results in Lung Cancer Staging
J. Nucl. Med., June 1, 2004; 45(6): 999 - 1003.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
F. C. Detterbeck, S. Falen, M. P. Rivera, J. S. Halle, and M. A. Socinski
Seeking a Home for a PET, Part 1: Defining the Appropriate Place for Positron Emission Tomography Imaging in the Diagnosis of Pulmonary Nodules or Masses
Chest, June 1, 2004; 125(6): 2294 - 2299.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
H. Nomori, K. Watanabe, T. Ohtsuka, T. Naruke, K. Suemasu, and K. Uno
The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer
J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 1087 - 1092.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
M. K. Gould, W. G. Kuschner, C. E. Rydzak, C. C. Maclean, A. N. Demas, H. Shigemitsu, J. K. Chan, and D. K. Owens
Test Performance of Positron Emission Tomography and Computed Tomography for Mediastinal Staging in Patients with Non-Small-Cell Lung Cancer: A Meta-Analysis
Ann Intern Med, December 2, 2003; 139(11): 879 - 892.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Cardiothorac SurgHome page
G. Leschber, G. Holinka, and A. Linder
Video-assisted mediastinoscopic lymphadenectomy (VAMLA) - a method for systematic mediastinal lymphnode dissection
Eur J Cardiothorac Surg, August 1, 2003; 24(2): 192 - 195.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. P. Mac Manus, R. J. Hicks, J. P. Matthews, A. McKenzie, D. Rischin, E. K. Salminen, and D. L. Ball
Positron Emission Tomography Is Superior to Computed Tomography Scanning for Response-Assessment After Radical Radiotherapy or Chemoradiotherapy in Patients With Non-Small-Cell Lung Cancer
J. Clin. Oncol., April 1, 2003; 21(7): 1285 - 1292.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
N. C. Gupta, J. S. Rogers, G. M. Graeber, J. L. Gregory, U. Waheed, D. Mullet, and M. Atkins
Clinical Role of F-18 Fluorodeoxyglucose Positron Emission Tomography Imaging in Patients With Lung Cancer and Suspected Malignant Pleural Effusion
Chest, December 1, 2002; 122(6): 1918 - 1924.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. G. Spiro and J. C. Porter
Lung Cancer--Where Are We Today?: Current Advances in Staging and Nonsurgical Treatment
Am. J. Respir. Crit. Care Med., November 1, 2002; 166(9): 1166 - 1196.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
N. Hollings and P. Shaw
Diagnostic imaging of lung cancer
Eur. Respir. J., April 1, 2002; 19(4): 722 - 742.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J.F. Vansteenkiste
Imaging in lung cancer: positron emission tomography scan
Eur. Respir. J., February 1, 2002; 19(35_suppl): 49S - 60s.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
W. B. Eubank, D. A. Mankoff, J. Takasugi, H. Vesselle, J. F. Eary, T. J. Shanley, J. R. Gralow, A. Charlop, G. K. Ellis, K. L. Lindsley, et al.
18Fluorodeoxyglucose Positron Emission Tomography to Detect Mediastinal or Internal Mammary Metastases in Breast Cancer
J. Clin. Oncol., August 1, 2001; 19(15): 3516 - 3523.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Cardiothorac SurgHome page
A. Imdahl, S. Jenkner, I. Brink, E. Nitzsche, E. Stoelben, E. Moser, and J. Hasse
Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions
Eur J Cardiothorac Surg, August 1, 2001; 20(2): 324 - 329.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. S. Silverman, R. E. Coleman, and M. E. Phelps
A Tabulated Summary of the FDG PET Literature
J. Nucl. Med., May 1, 2001; 42(90050): 1S - 93.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
J.F. Vansteenkiste and S.G. Stroobants
The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology
Eur. Respir. J., April 1, 2001; 17(4): 802 - 820.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
M. K. Gould, C. C. Maclean, W. G. Kuschner, C. E. Rydzak, and D. K. Owens
Accuracy of Positron Emission Tomography for Diagnosis of Pulmonary Nodules and Mass Lesions: A Meta-analysis
JAMA, February 21, 2001; 285(7): 914 - 924.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
K. Pacak, W. M. Linehan, G. Eisenhofer, M. M. Walther, and D. S. Goldstein
Recent Advances in Genetics, Diagnosis, Localization, and Treatment of Pheochromocytoma
Ann Intern Med, February 20, 2001; 134(4): 315 - 329.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
T. W. McCain, D. P. Dunagan, R. Chin Jr., T. Oaks, B. A. Harkness, and E. F. Haponik
The Usefulness of Positron Emission Tomography in Evaluating Patients for Pulmonary Malignancies
Chest, December 1, 2000; 118(6): 1610 - 1615.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
J. J. Erasmus, H. P. McAdams, S. E. Rossi, P. C. Goodman, R. E. Coleman, and E. F. Patz
FDG PET of Pleural Effusions in Patients with Non--Small Cell Lung Cancer
Am. J. Roentgenol., July 1, 2000; 175(1): 245 - 249.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
E. F. Patz Jr
1999 Plenary Session: Friday Imaging Symposium : Evaluation of Focal Pulmonary Abnormalities with FDG PET
RadioGraphics, July 1, 2000; 20(4): 1182 - 1185.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
E. F. Patz Jr., J. Connolly, and J. Herndon
Prognostic Value of Thoracic FDG PET Imaging After Treatment for Non-Small Cell Lung Cancer
Am. J. Roentgenol., March 1, 2000; 174(3): 769 - 774.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
S. Kosuda, K. Ichihara, M. Watanabe, H. Kobayashi, and S. Kusano
Decision-Tree Sensitivity Analysis for Cost-Effectiveness of Chest 2-Fluoro-2-D-[18F]Fluorodeoxyglucose Positron Emission Tomography in Patients With Pulmonary Nodules (Non-small Cell Lung Carcinoma) in Japan
Chest, February 1, 2000; 117(2): 346 - 353.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
J. J. Erasmus, H. P. McAdams, and J. E. Connolly
Solitary Pulmonary Nodules: Part II. Evaluation of the Indeterminate Nodule
RadioGraphics, January 1, 2000; 20(1): 59 - 66.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
B. A. Dwamena, S. S. Sonnad, J. O. Angobaldo, and R. L. Wahl
Metastases from Non-Small Cell Lung Cancer: Mediastinal Staging in the 1990s-Meta-analytic Comparison Of PET and CT
Radiology, November 1, 1999; 213(2): 530 - 536.
[Abstract] [Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
G. M. Graeber, N. C. Gupta, and G. F. Murray
POSITRON EMISSION TOMOGRAPHIC IMAGING WITH FLUORODEOXYGLUCOSE IS EFFICACIOUS IN EVALUATING MALIGNANT PULMONARY DISEASE
J. Thorac. Cardiovasc. Surg., April 1, 1999; 117(4): 719 - 727.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
W. J. Scott, J. Shepherd, and S. S. Gambhir
Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis
Ann. Thorac. Surg., December 1, 1998; 66(6): 1876 - 1883.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
W. J. Scott, L. S. Gobar, J. D. Terry, N. A. Dewan, J. J. Sunderland, and S.:A. G. Little
MEDIASTINAL LYMPH NODE STAGING OF NON-SMALL-CELL LUNG CANCER: A PROSPECTIVE COMPARISON OF COMPUTED TOMOGRAPHY AND POSITRON EMISSION TOMOGRAPHY
J. Thorac. Cardiovasc. Surg., March 1, 1996; 111(3): 642 - 648.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
P. E. Valk, T. R. Pounds, D. M. Hopkins, M. K. Haseman, G. A. Hofer, H. B. Greiss, R. W. Myers, and C. L. Lutrin
Staging non--small cell lung cancer by whole-body positron emission tomographic imaging
Ann. Thorac. Surg., December 1, 1995; 60(6): 1573 - 1582.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
F. G. Duhaylongsod, V. J. Lowe, E. F. Patz Jr, A. L. Vaughn, R. E. Coleman, and W. G. Wolfe
Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography
Ann. Thorac. Surg., November 1, 1995; 60(5): 1348 - 1352.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1994 by The Society of Thoracic Surgeons.